2. Garg A, Gupta V, Gaikwad SB, Mishra NK, Ojha BK, Chugh M, et al. Scalp malignant peripheral nerve sheath tumor (MPNST) with bony involvement and new bone formation: case report. Clin Neurol Neurosurg. 2004; 106:340-4.10.1016/j.clineuro.2004.01.003
3. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993; 71:1247-53.10.1002/1097-0142(19930215)71:4<;1247::AID-CNCR2820710413>3.0.CO;2-S
6. Sangueza OP, Requena L. Neoplasms with neural differentiation: a review. Part II: Malignant neoplasms. Am J Dermatopathol. 1998; 20:89-102.10.1097/00000372-199802000-00018
7. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 1995; 164:129-34.10.2214/ajr.164.1.7998525
10. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer. 1990; 66:1253-65.10.1002/1097-0142(19900915)66:6<;1253::AID-CNCR2820660627>3.0.CO;2-R
11. Mikami Y, Hidaka T, Akisada T, Takemoto T, Manabe T. Malignant peripheral nerve sheath tumor arising in benign ancient schwannoma: a case report with an immunohistochemical study. Pathol Int. 2000; 50: 156-61.10.1046/j.1440-1827.2000.01019.x
12. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986; 314:1010-5.
13. Kourea HP, Bilsky MH, Leung DH, Lewis JJ, Woodruff JM. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer. 1998; 82:2191-203.10.1002/(SICI)1097-0142(19980601)82:11<;2191::AID-CNCR14>3.0.CO;2-P
15. Chijiwa K, Uchida K, Tateyama S. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas. Vet Pathol. 2004; 41: 307-18.10.1354/vp.41-4-307
16. Kindblom LG, Ahlden M, Meis-Kindblom JM, Stenman G. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours. Virchows Arch. 1995; 427: 19-26.10.1007/BF00203733
17. Kar M, Deo SV, Shukla NK, Malik A, DattaGupta S, Mohanti BK, et al. Malignant peripheral nerve sheath tumors (MPNST)-clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol. 2006; 4:55.10.1186/1477-7819-4-55
18. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg. 2009; 249:1014-22.10.1097/SLA.0b013e3181a77e9a
19. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res. 2002; 62: 1573-7.
20. Angelov L, Davis A, O’Sullivan B, Bell R, Guha A. Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery. 1998; 43:56-64.10.1097/00006123-199807000-00035
23. Shin M, Ueki K, Kurita H, Kirino T. Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet. 2002; 360:309-10.10.1016/S0140-6736(02)09521-1